Latest Vagus nerve stimulation Stories
HOUSTON, Sept. 17 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced, as required under NASDAQ Listing Rule 5635(c)(4), that the Compensation Committee of its Board of Directors approved an award from its Amended and Restated New Employee Equity Inducement Plan of 800 shares of restricted stock and an option to purchase 2,000 shares of its common stock for $24.55 per share, the closing price of the company's stock on September 15, 2010, the date of the award, to...
HOUSTON, Sept. 13 /PRNewswire/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that it will present at two conferences this month. Dan Moore, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21, 2010 at 1:00 PM EDT. UBS will host a webcast of the presentation live and by replay at http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=66_7PVQHBG. The conference webcast replay will be available for 90 days...
HOUSTON, Aug. 24 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that it has entered into additional agreements with NeuroVista Corporation in the field of EEG-based seizure detection to build on its position as the leader in medical devices for epilepsy. In October 2009, the company announced that it had licensed NeuroVista technology related to a seizure detection algorithm, a rechargeable battery system, wireless communication, and an implantable lead. In July...
HOUSTON, Aug. 11 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the first quarter ended July 30, 2010 of its fiscal year ending April 29, 2011 on Wednesday, August 25, 2010 at 5:00 PM EDT. The company will conduct a conference call to discuss those results on Thursday, August 26, 2010 at 9:00 AM EDT. Fiscal Year 2011 First Quarter Results Conference Call Instructions To listen to the conference call live by...
HOUSTON, Aug. 9 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq:CYBX) today announced that Jon T. Tremmel has been nominated to stand for election to its Board of Directors. Mr. Tremmel will replace Reese Terry, a director since December 1987, who has announced his intention not to stand for re-election at the Annual Meeting on September 23, 2010. Mr. Tremmel was President of Medtronic, Inc.'s Neurological Division from March 2003 to April 2007 and President of Medtronics's...
MOUNTAIN VIEW, Calif., June 8 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data from a previously reported phase 2 study evaluating the safety and efficacy of the investigational drug Qnexa® for the treatment of obstructive sleep apnea (OSA) were presented at SLEEP 2010, the 24th Annual Meeting of the Associated Professional Sleep Societies (APSS). Data from the study entitled, "A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of...
HOUSTON, May 27 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced the results of a multicenter, double-blind, randomized dosing study (D-21) conducted as a condition of the Food and Drug Administration (FDA) approval for VNS Therapy for patients with chronic and recurrent treatment-resistant depression in July 2005. This dosing study showed a consistent, sustained and clinically meaningful decrease in depression symptoms across all treatment groups as measured by...
HOUSTON, May 25 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the Jefferies 2010 Global Life Sciences Conference in New York on Thursday, June 10, 2010 at 3:30 PM EDT. Jefferies will host a webcast of the presentation live and by replay at http://www.wsw.com/webcast/jeff46/cybx/. The conference webcast replay will be available for 90 days following...
HOUSTON, May 12 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the fourth quarter and fiscal year ended April 30, 2010 on Wednesday, June 2, 2010 at 5:00 PM EDT. The company will conduct a conference call to discuss those results on Thursday, June 3, 2010 at 9:00 AM EDT. Fourth Quarter and Fiscal Year 2010 Results Conference Call Instructions To listen to the conference call live by telephone dial 877-313-8035...
Trial of non-invasive treatment used new, convincing sham controlSome depressed patients who don't respond to or tolerate antidepressant medications may benefit from a non-invasive treatment that stimulates the brain with a pulsing electromagnet, a study suggests. This first industry-independent, multi-site, randomized, tightly controlled trial of repetitive transcranial magnetic stimulation (rTMS) found that it produced significant antidepressant effects in a subgroup of patients, with few...
